Deconvoluting Compound-Target Interactions with Limited Proteolysis (LiP) - Biognosys

Deconvoluting Compound-Target Interactions with Limited Proteolysis (LiP)

This joint webinar with ETH Zurich features Prof. Dr. Paola Picotti, scientific advisor of Biognosys and inventor of the LiP-MS technology. In the first part of the webinar, Prof. Picotti provides an overview on the development of the LiP-MS workflow in her laboratory starting from the concept of detecting protein structural alterations in complex matrices to its various applications in addressing biological questions such as metabolite-protein interactions, protein aggregation and thermal stability. In the second part of this webinar, Biognosys’ senior scientist Dr. Nigel Beaton focuses on establishing a machine learning-based LiP-MS workflow for the deconvolution of small molecule drug targets in an unbiased manner.

Back to Resources overview

Helpdesk

Access our knowledge base with relevant resources and guiding information.

Contact

    Close banner

    SpectroDive™ 11

    Straightforward Validation
    of Your Protein Targets

    New: SpectroDive™ 11

    Straightforward Validation of Your Protein Targets

    learn more